Medigen Biotechnology Corp (3176)-Pharmaceuticals & Healthcare-Deals and Alliances Profile
May 2017
29
About the Report
About the Report
Summary
Medigen Biotechnology Corp (MBC) is a pharmaceutical company that carries out the research and development of biopharmaceuticals for the treatment of liver diseases and cancers. It focuses at developing new therapeutics, principally in the area of cancer and liver diseases. The company's product portfolio includes monoclonal antibodies; vaccines; molecular diagnostics and generic drugs. MBC also provides original equipment manufacturing (OEM) and original design manufacturing (ODM) manufacturing services in various dosage forms including orals, externals, ophthalmic and hormones; nutrition supplements; cosmeceutical products. 's subsidiaries include Medigen Vaccine Biologics; TBG Biotechnology Corp.; and Winston Medical Supply Co., Ltd. MBC is headquartered in Taipei city, Taiwan.
Medigen Biotechnology Corp (3176)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
Business Description-A brief description of the company's operations.
Key Employees-A list of the key executives of the company.
Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors-A list of the key competitors of the company.
Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Medigen Biotechnology Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Medigen Biotechnology Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Medigen Biotechnology Corp, Medical Devices Deals, 2011 to YTD 2017 9
Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Medigen Biotech Acquires B-cell Immortalization Platform Technology 12
Partnerships 12
Medigen Biotech to Form Joint Venture for Vaccine Technology 12
Licensing Agreements 13
Medigen Vaccine Biologics Enters into Licensing Agreement with National Institutes of Health for Dengue Vaccine 13
Progen Pharma To Enter Into Licensing Agreement With Medigen Biotech For PG545 13
Equity Offering 15
Medigen Vaccine Biologics to Raise Up to USD15.8 Million in Private Placement of Shares 15
Medigen Vaccine Biologics to Raise up to USD13.5 Million in Private Placement of Shares 15
Medigen Vaccine Biologics Raises USD13.5 Million in Rights Offering of Shares 16
Medigen Biotech to Raise Funds in Public Offering of Shares 17
Medigen Vaccine Biologics Raises USD28.8 Million in IPO 17
Medigen Biotech Completes Public Offering Of Shares For US$4 Million 18
Medigen Biotech Completes Rights Offering Of Shares For US$32 Million 19
Medigen Biotech Announces Rights Offering Of Shares For US$21 Million 20
Medigen Biotech Announces Public Offering Of Shares For US$2.7 Million 20
Medigen Biotech Prices Public Offering Of Common Stock For US$10 Million 21
Acquisition 22
United Microelectronics Acquires 8% Stake in Medigen for USD4 Million 22
Medigen Biotech To Acquire 67.92% Stake In Winston Medical 23
PerkinElmer Acquires Shanghai Haoyuan Biotech From Medigen Biotech For US$38 Million 23
Medigen Biotech Acquires Remaining Stake In Texas BioGene 25
Medigen Biotechnology Corp-Key Competitors 26
Key Employees 27
Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29
List of Figure
List of Figures
Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Medigen Biotechnology Corp, Medical Devices Deals, 2011 to YTD 2017 9
List of Table
List of Tables
Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Medigen Biotechnology Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Medigen Biotechnology Corp, Deals By Therapy Area, 2011 to YTD 2017 8
Medigen Biotechnology Corp, Medical Devices Deals, 2011 to YTD 2017 9
Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Medigen Biotech Acquires B-cell Immortalization Platform Technology 12
Medigen Biotech to Form Joint Venture for Vaccine Technology 12
Medigen Vaccine Biologics Enters into Licensing Agreement with National Institutes of Health for Dengue Vaccine 13
Progen Pharma To Enter Into Licensing Agreement With Medigen Biotech For PG545 13
Medigen Vaccine Biologics to Raise Up to USD15.8 Million in Private Placement of Shares 15
Medigen Vaccine Biologics to Raise up to USD13.5 Million in Private Placement of Shares 15
Medigen Vaccine Biologics Raises USD13.5 Million in Rights Offering of Shares 16
Medigen Biotech to Raise Funds in Public Offering of Shares 17
Medigen Vaccine Biologics Raises USD28.8 Million in IPO 17
Medigen Biotech Completes Public Offering Of Shares For US$4 Million 18
Medigen Biotech Completes Rights Offering Of Shares For US$32 Million 19
Medigen Biotech Announces Rights Offering Of Shares For US$21 Million 20
Medigen Biotech Announces Public Offering Of Shares For US$2.7 Million 20
Medigen Biotech Prices Public Offering Of Common Stock For US$10 Million 21
United Microelectronics Acquires 8% Stake in Medigen for USD4 Million 22
Medigen Biotech To Acquire 67.92% Stake In Winston Medical 23
PerkinElmer Acquires Shanghai Haoyuan Biotech From Medigen Biotech For US$38 Million 23
Medigen Biotech Acquires Remaining Stake In Texas BioGene 25
Medigen Biotechnology Corp, Key Competitors 26
Medigen Biotechnology Corp, Key Employees 27
Medigen Biotechnology Corp, Other Locations 28
Medigen Biotechnology Corp, Subsidiaries 28
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.